These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17482357)

  • 1. Genetic analysis of LRRK2 P755L variant in Caucasian patients with Parkinson's disease.
    Deng H; Le W; Huang M; Xie W; Pan T; Jankovic J
    Neurosci Lett; 2007 May; 419(2):104-7. PubMed ID: 17482357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 P755L variant in sporadic Parkinson's disease.
    Tomiyama H; Mizuta I; Li Y; Funayama M; Yoshino H; Li L; Murata M; Yamamoto M; Kubo SI; Mizuno Y; Toda T; Hattori N
    J Hum Genet; 2008; 53(11-12):1012-1015. PubMed ID: 18923807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three novel LRRK2 mutations associated with Parkinson's disease in a Calabrian population.
    Anfossi M; Colao R; Gallo M; Bernardi L; Conidi ME; Frangipane F; Vasso F; Puccio G; Clodomiro A; Mirabelli M; Curcio SA; Torchia G; Smirne N; Di Lorenzo R; Maletta R; Bruni AC
    J Alzheimers Dis; 2014; 38(2):351-7. PubMed ID: 23963289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
    Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
    Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 is not a significant cause of Parkinson's disease in French-Canadians.
    Dupré N; Rivière JB; Myers RH; Provencher P; Pourcher E; Emond F; Rouleau GA
    Can J Neurol Sci; 2007 Aug; 34(3):333-5. PubMed ID: 17803032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
    Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
    Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of LRRK2 P755L variant in Parkinson's disease.
    Tan EK; Lim HQ; Yuen Y; Zhao Y
    Mov Disord; 2008 Apr; 23(5):734-6. PubMed ID: 18265005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.
    Fung HC; Chen CM; Hardy J; Singleton AB; Wu YR
    BMC Neurol; 2006 Dec; 6():47. PubMed ID: 17187665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.
    Thaler A; Ash E; Gan-Or Z; Orr-Urtreger A; Giladi N
    J Neural Transm (Vienna); 2009 Nov; 116(11):1473-82. PubMed ID: 19756366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRRK2 and Parkinson's disease in Norway.
    Toft M; Haugarvoll K; Ross OA; Farrer MJ; Aasly JO
    Acta Neurol Scand Suppl; 2007; 187():72-5. PubMed ID: 17419834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population.
    Funayama M; Li Y; Tomiyama H; Yoshino H; Imamichi Y; Yamamoto M; Murata M; Toda T; Mizuno Y; Hattori N
    Neuroreport; 2007 Feb; 18(3):273-5. PubMed ID: 17314670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.
    Ross OA; Wu YR; Lee MC; Funayama M; Chen ML; Soto AI; Mata IF; Lee-Chen GJ; Chen CM; Tang M; Zhao Y; Hattori N; Farrer MJ; Tan EK; Wu RM
    Ann Neurol; 2008 Jul; 64(1):88-92. PubMed ID: 18412265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.
    Zabetian CP; Yamamoto M; Lopez AN; Ujike H; Mata IF; Izumi Y; Kaji R; Maruyama H; Morino H; Oda M; Hutter CM; Edwards KL; Schellenberg GD; Tsuang DW; Yearout D; Larson EB; Kawakami H
    Mov Disord; 2009 May; 24(7):1034-41. PubMed ID: 19343804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
    Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.
    Cho JW; Kim SY; Park SS; Kim HJ; Ahn TB; Kim JM; Jeon BS
    Can J Neurol Sci; 2007 Feb; 34(1):53-5. PubMed ID: 17352347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.